PD-1 and PD-L1 inhibitors act to inhibit the association of the programmed death-ligand 1 (PD-L1) with its receptor, programmed cell death protein 1 (PD-1).
IL-6
Z-IETD-FMK : mTOR Inhibition Sensitizes ONC201-Induced Anti-Colorectal Cancer Cell Activity